Olive Leaf Extracts in the Control of Cardiovascular Risk
Sponsored by University of Monastir
About this trial
Last updated 2 years ago
Study ID
Atherolive
Status
Recruiting
Type
Interventional
Phase
Phase 2/Phase 3
Placebo
No
Accepting
18 to 100 Years
All
Trial Timing
Ended a year ago
What is this trial about?
This study will be carried out in 2 emergency departments (at the exit of the emergency
room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology
consultation, Jemmal hospital).
Patients over 18 years of age with:
1. Arterial hypertension (hypertension).
2. Or diabetes.
3. Or one or more other cardiovascular risk factors (AHA, ESC) or risk of
cardiovascular disease> 20% according to the Framingham scale (apart from
hypertension and diabetes were included.
What are the participation requirements?
Inclusion Criteria
- Patients over 18 years of age with: 1. Arterial hypertension (hypertension). 2. Or diabetes. 3. Or one or more other cardiovascular risk factors (AHA, ESC) or risk of cardiovascular disease> 20% according to the Framingham scale (apart from hypertension and diabetes. Criteria exclusion: -. Exclusion criteria: None.
Exclusion Criteria
Locations
Location
Status
Recruiting